Rituximab-arrx is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, granulomatosis with polyangiitis and microscopic polyangiitis. It is a biosimilar to Rituxan.
Rituximab-arrx is a prescription medication used to treat certain types of non-Hodgkin's lymphoma (a type of cancer that begins in a type of white blood cells that normally fights infection) and chronic lymphocytic leukemia (a type of cancer that begins in the white blood cells).
Rituximab-arrx is also used with other medications to treat granulomatosis with polyangiitis (Wegener's Granulomatosis) and microscopic polyangiitis, which are conditions in which the body attacks its own veins and other blood vessels and causes damage to organs, such as the heart and lungs.
Rituximab-arrx belongs to a group of drugs called monoclonal antibodies. It works by killing cancer cells and blocking activation of the immune system.
This medication is available in an injectable form to be given directly into a vein (IV) by a healthcare professional.
Common side effects include infections, diarrhea, back or joint pain, and anxiety. Rituximab-arrx can cause dizziness and blurred vision. Do not drive or operate heavy machinery until you know how rituximab-arrx affects you.
How was your experience with ?
rituximab-arrx Brand Names
rituximab-arrx may be found in some form under the following brand names:
rituximab-arrx Drug Class
rituximab-arrx is part of the drug class: